arrow
李

李斌奎 (Binkui Li)

sun yat sen university
H指数:34
被引数:4,117

个人简介

"2001年于中山医科大学临床医学系本科毕业。2010年于中山大学博士研究生毕业。2013到2014年美国MD Anderson癌症中心国家公派访问学者。广东省杰出青年医学人才(第一批)。 主要从事肝癌的综合治疗,包括外科治疗、介入治疗、靶向治疗、免疫治疗等。临床上致力于早期肝癌的精细和微创外科手术、中晚期肝癌的降期转化治疗,使部分不可切除的肝癌转化为可手术切除,为每一位患者制订一套合理化多学科联合的个体化综合治疗方案,从而提高患者疗效和改善患者生活质量。 作为结直肠癌的多学科会诊(Multi-Disciplinary Team, MDT)专家组成员,擅长结直肠癌肝转移的外科治疗。对复杂、广泛肝转移的外科手术治疗具有丰富经验。"

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic Significance of SOX9 and Its Combination With RAS and TP53 Mutations Following Colorectal Cancer Liver Metastasectomy

结直肠癌肝转移切除术后SOX9的预后意义及其与RAS和TP53突变的联合作用

2025-12-120
PRE
The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA

INSPECTOR研究:基于酶辅助高信噪比测序甲基化循环肿瘤DNA的多癌种早期检测方法的临床转化可行性提升

2025-10-300
OAAI
Percutaneous hepatic artery infusion chemotherapy with oxaliplatin and fluoropyrimidines in treatment-resistant colorectal cancer patients with unresectable liver metastases: a retrospective cohort study

经皮肝动脉灌注化疗(奥沙利铂和氟嘧啶类)治疗难治性结直肠癌伴不可切除性肝转移:一项回顾性队列研究

HPB
IF2.4
2025-03-010
OAAI
Safety and efficacy of adjuvant FOLFOX/FOLFIRI with versus without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastasectomy (HARVEST trial): A randomized controlled trial
2025-01-010
OAAI
Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): Preliminary results of a single-arm, multicenter phase II trial

信迪利单抗联合安罗替尼与序贯化疗治疗晚期三阴性乳腺癌(SPACE)的疗效与安全性:一项单臂、多中心II期研究的初步结果

2024-09-010
PRE
Atezolizumab and bevacizumab plus transarterial chemoembolization and hepatic arterial infusion chemotherapy for patients with high tumor burden unresectable hepatocellular carcinoma: A multi-center cohort study

阿特珠单抗和贝伐单抗联合肝动脉化疗栓塞和肝动脉灌注化疗治疗高肿瘤负荷不可切除肝癌的多中心队列研究

2024-09-011
PRE
TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study

Tace-haic联合靶向治疗和免疫治疗与单纯TACE治疗肝细胞癌合并门静脉癌栓的倾向评分匹配研究

2023-05-0149
OAAI
S100A9 Derived from Chemoembolization-Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression

化疗栓塞诱导的缺氧衍生的S100A9调控肝细胞癌进展中的线粒体功能

2022-08-3039
OAAI